A panel of experts discusses recent updates in the role of bispecific antibodies in the treatment of multiple myeloma and the optimal sequencing strategies.
EP. 1: Patient Case 1: A 68-Year-Old with R/R MM Treated with TeclistamabMay 24th 2023
Jack Khouri, MD, presents the case of a 68-year-old patient with relapsed/refractory multiple myeloma and extramedullary disease treated with teclistamab.
EP. 2: Selecting Patients with MM for Teclistamab and Optimal SequencingMay 24th 2023
The panel discusses their potential treatment approaches for the presented patient case and how they select patients with relapsed/refractory MM for teclistamab and optimally sequence therapies.